Published in Drug Intell Clin Pharm on October 24, 1988
Pharmacokinetics of ampicillin and sulbactam in pediatric patients. Antimicrob Agents Chemother (1999) 0.83
Population pharmacokinetics of ampicillin and sulbactam in patients with community-acquired pneumonia: evaluation of the impact of renal impairment. Br J Clin Pharmacol (2014) 0.81
Ampicillin/Sulbactam vs. Cefoxitin for the treatment of pelvic inflammatory disease. Infect Dis Obstet Gynecol (1997) 0.75
Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. Drug Saf (2000) 2.37
Efficacy of diazepam and meperidine in ambulatory pediatric patients undergoing endoscopy: a randomized, double-blind trial. J Pediatr Gastroenterol Nutr (1993) 2.19
The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin. Ann Pharmacother (1992) 2.13
Once-daily administration of aminoglycosides. Ann Pharmacother (1994) 1.73
Teaching paediatric pharmacotherapy at colleges of pharmacy in the United States and Canada. J Clin Pharm Ther (1994) 1.48
Issues facing clinical pharmacy education for undergraduate students. DICP (1989) 1.40
Standard room temperature needed for stability and compatibility studies. Am J Hosp Pharm (1993) 1.39
Role of the ketogenic diet in children with intractable seizures. Ann Pharmacother (1998) 1.39
Treatment of listeriosis. Ann Pharmacother (2000) 1.32
Need for conducting research on medications unlabeled for use in pediatric patients. Ann Pharmacother (1994) 1.30
Clinical use of systemic antifungal agents. Clin Pharm (1988) 1.23
Clinical pharmacokinetics of antibacterial drugs in neonates. Clin Pharmacokinet (1990) 1.21
Chloramphenicol serum concentration falls during chloramphenicol succinate dosing. Clin Pharmacol Ther (1983) 1.16
Glycerol: a review of its pharmacology, pharmacokinetics, adverse reactions, and clinical use. Pharmacotherapy (1986) 1.12
Pediatric drug formulations: challenges and potential solutions. Ann Pharmacother (1999) 1.09
Pharmacokinetics of amphotericin B in children. Antimicrob Agents Chemother (1989) 1.07
Dosage guidelines for the use of vancomycin based on its pharmacokinetics in infants. Eur J Clin Pharmacol (1988) 1.05
Complication of intranasal midazolam. Pediatrics (1993) 1.03
Treatment and prevention of infections of cerebrospinal fluid shunts. Clin Pharm (1987) 1.03
Positive impact of a therapeutic drug-monitoring program on total aminoglycoside dose and cost of hospitalization. Ther Drug Monit (1987) 1.02
Pathogenesis and treatment of bronchiolitis. Clin Pharm (1993) 0.99
Nelfinavir mesylate: a protease inhibitor. Ann Pharmacother (1999) 0.96
Acetaminophen accumulation in pediatric patients after repeated therapeutic doses. Eur J Clin Pharmacol (1984) 0.95
Variation in morphine pharmacokinetics in children with cancer. Dev Pharmacol Ther (1985) 0.95
Lack of nephrotoxicity in pediatric patients receiving concurrent vancomycin and aminoglycoside therapy. Chemotherapy (1987) 0.95
A comparative review of conventional and lipid formulations of amphotericin B. J Clin Pharm Ther (1999) 0.95
Adverse effects of meperidine, promethazine, and chlorpromazine for sedation in pediatric patients. Clin Pediatr (Phila) (1985) 0.94
Effect of gestational age and birth weight on tobramycin kinetics in newborn infants. J Antimicrob Chemother (1984) 0.94
Antimicrobial dosages in guidelines for prevention of bacterial endocarditis. Clin Pharm (1991) 0.94
Determination of cefaclor by high-performance liquid chromatography. J Chromatogr (1982) 0.94
Pharmacokinetics of dexamethasone in premature neonates. Eur J Clin Pharmacol (1996) 0.93
Ganciclovir--a review of pharmacology, therapeutic efficacy and potential use for treatment of congenital cytomegalovirus infections. J Clin Pharm Ther (1989) 0.93
Clinical use of trimethoprim/sulfamethoxazole during renal dysfunction. DICP (1989) 0.93
Efficacy of amlodipine in pediatric patients with hypertension. Pediatr Nephrol (1999) 0.92
Salivary concentrations of ketoconazole and fluconazole: implications for drug efficacy in oropharyngeal and esophageal candidiasis. Ann Pharmacother (1995) 0.92
Effect of infusion methods on tobramycin serum concentrations in newborn infants. J Pediatr (1984) 0.91
Pharmacokinetics of cefuroxime axetil suspension in infants and children. Antimicrob Agents Chemother (1991) 0.91
Oral terbinafine: a new antifungal agent. Ann Pharmacother (1997) 0.90
Delivery of tobramycin by three infusion systems. Chemotherapy (1984) 0.89
Pharmacokinetics and safety of tobramycin after once-daily administration in patients with cystic fibrosis. Chest (1997) 0.89
Efficacy and safety of aerosolized tobramycin in cystic fibrosis. Pediatr Pulmonol (2001) 0.89
Pharmacokinetics of netilmicin in premature infants. Eur J Clin Pharmacol (1986) 0.88
Bacterial contamination of aerosol solutions used to treat cystic fibrosis. Am J Hosp Pharm (1982) 0.87
Bioavailability and clearance of chloramphenicol after intravenous chloramphenicol succinate. Clin Pharmacol Ther (1981) 0.87
Research productivity and funding. DICP (1991) 0.87
Treatment of irritable bowel syndrome. J Clin Pharm Ther (2010) 0.85
Pharmacokinetics of phenytoin in children with acute neurotrauma. Crit Care Med (1995) 0.85
Clinical uses of fentanyl, sufentanil, and alfentanil. Clin Pharm (1991) 0.84
Interlot variability in gentamicin and tobramycin concentration and its possible significance. Ther Drug Monit (1986) 0.84
Effect of ascorbic acid on urine pH in man. Am J Hosp Pharm (1977) 0.84
Efficacy of ototopical ciprofloxacin in pediatric patients with otorrhea. Otolaryngol Head Neck Surg (1997) 0.84
Chronic suppurative otitis media. Ann Pharmacother (1994) 0.83
Pharmacologic management of patent ductus arteriosus. Clin Pharm (1989) 0.83
Treatment of pediatric hypertension. Pharmacotherapy (2000) 0.83
Moxalactam epimer kinetics in children. Clin Pharmacol Ther (1982) 0.82
Cephalexin pharmacokinetics in patients with cystic fibrosis. Dev Pharmacol Ther (1984) 0.82
Periorbital cellulitis secondary to Conidiobolus incongruus. Pharmacotherapy (2001) 0.82
Tobramycin pharmacokinetics in very low birth weight infants. Br J Clin Pharmacol (1986) 0.82
Gastrostomy tube placement in nonadherent HIV-infected children. Ann Pharmacother (2001) 0.82
Interactions among chloramphenicol, phenytoin, and phenobarbital in a pediatric patient. J Pediatr (1981) 0.82
Dopamine and dobutamine in pediatric therapy. Pharmacotherapy (1989) 0.82
Tobramycin kinetics in newborn infants. J Pediatr (1983) 0.81
Effect of intravenous flow rate and injection site on in vitro delivery of chloramphenicol succinate and in vivo kinetics. J Pediatr (1981) 0.81
Pharmacokinetics and cerebrospinal fluid (CSF) concentrations of vancomycin in pediatric patients undergoing CSF shunt placement. Chemotherapy (1990) 0.81
The safety and antiviral effect of protease inhibitors in children. Pharmacotherapy (2001) 0.81
Comparative bioavailability and pharmacokinetics of chloramphenicol after intravenous chloramphenicol succinate in premature infants and older patients. Dev Pharmacol Ther (1983) 0.80
Response to initial griseofulvin therapy in pediatric patients with tinea capitis. Ann Pharmacother (1997) 0.80
Juvenile amaurotic family idiocy with cherry-red spot and cataract. Indian J Ophthalmol (1973) 0.80
Dopamine pharmacokinetics in critically ill newborn infants. Eur J Clin Pharmacol (1991) 0.80
Comparative palatability of 22 liquid antacids. Aliment Pharmacol Ther (2000) 0.80
Variations in glycerol kinetics in Reye's syndrome. Clin Pharmacol Ther (1981) 0.80
Palatability of 14 over-the-counter antacids. Am Pharm (1994) 0.80
Rimantadine: a clinical perspective. Ann Pharmacother (1995) 0.80
Clinical use of fluoroquinolones in children. Ann Pharmacother (2000) 0.80
Duration of penicillin prophylaxis in sickle cell anemia: issues and controversies. Pharmacotherapy (2000) 0.79
Effect of histamine H2-receptor antagonists on vitamin B12 absorption. Ann Pharmacother (1992) 0.79
Simultaneous determination of chloramphenicol and its succinate ester by high-performance liquid chromatography. J Chromatogr (1981) 0.79
Trovafloxacin: a new fluoroquinolone. Ann Pharmacother (1999) 0.79
A comparative study of anti-fungal drugs in mycotic corneal ulcer. Indian J Ophthalmol (1987) 0.79
Pharmacotherapy of lower limb diabetic ulcers. J Am Geriatr Soc (2000) 0.79
Respiratory syncytial virus (RSV) immune globulin and palivizumab for prevention of RSV infection. Am J Health Syst Pharm (2000) 0.79
Efficacy of itraconazole in children with Trichophyton tonsurans tinea capitis. J Am Acad Dermatol (1998) 0.79
High-performance liquid chromatographic determination of cephalexin in human plasma, urine and saliva. J Chromatogr (1981) 0.79
Stability of dopamine hydrochloride injection in the presence of dobutamine hydrochloride, tolazoline hydrochloride, and theophylline injections. J Perinatol (1990) 0.78
Stability of ceftriaxone sodium in intravenous solutions. Am J Hosp Pharm (1983) 0.78
Pharmacokinetics of gabapentin in paediatric patients with uncontrolled seizures. J Clin Pharm Ther (2004) 0.78
Topical ciprofloxacin for otorrhea after tympanostomy tube placement. Arch Otolaryngol Head Neck Surg (1995) 0.78
Absorption of theophylline from the small and large intestine of the neonatal piglet. Eur J Drug Metab Pharmacokinet (1994) 0.78
Dirithromycin: a new macrolide. Ann Pharmacother (1996) 0.78
Dosage regimens of trimethoprim/sulfamethoxazole (TPM/SMX) in patients with renal dysfunction. Ann Pharmacother (1995) 0.78
Sedation with meperidine and midazolam in pediatric patients undergoing endoscopy. Eur J Clin Pharmacol (1994) 0.78
Ceftriaxone kinetics and cerebrospinal fluid penetration in infants and children with meningitis. Chemotherapy (1986) 0.78
Chloramphenicol: new perspectives on an old drug. Drug Intell Clin Pharm (1982) 0.78
Pharmacokinetics of cefotaxime and its active metabolite in children with renal dysfunction. Antimicrob Agents Chemother (1991) 0.77
Prevention and treatment of osteoporosis in the cystic fibrosis population. J Pediatr Health Care (2001) 0.77
Interaction between ciprofloxacin and rifampin. Ann Pharmacother (1999) 0.77
Haemophilus influenzae type B conjugate vaccines. Ann Pharmacother (1992) 0.77
Aerosolized furosemide in the treatment of acute respiratory distress and possible bronchopulmonary dysplasia in preterm neonates. Ann Pharmacother (2000) 0.77